HealthcareDrug Discovery and DeliveryAI-powered Drug DiscoveryDeep LearningTherapeutics https://www.macromoltek.com ↗
Company facts
Early-stage
- Founded
- 2017
- Employees
- 14
- Headquarters
- United States
About
Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.